Surprisingly, my weight loss journey turned out to be an exciting one with real transformation
39637874 Gettings JV, Mohammad Alizadeh Chafjiri F, Patel AA, Shorvon S, Goodkin HP, Loddenkemper T
Target Audience : high-intensity sports (heavy weightlifting, sprints, interval training, CrossFit), particularly useful during cutting phase where effort is more demanding
Orlistat, phentermine/topiramate, naltrexone/bupropion, and the incretin-based drugs liraglutide and semaglutide, both GLP-1 receptor agonists (GLP-1RA), and tirzepatide, a biased dual GIP/GLP-1 receptor agonist, are currently both FDA and EMA approved for the management of non-syndromic obesity 10
Medication adjustments, protein optimization, and resistance training often help move through these phases safely